Results
|
|
261.
|
Phase I and pharmacokinetic study of a water-soluble etoposide prodrug, etoposide phosphate (BMY-40481). [electronic resource] by
- Millward, M J
- Newell, D R
- Mummaneni, V
- Igwemezie, L N
- Balmanno, K
- Charlton, C J
- Gumbrell, L
- Lind, M J
- Chapman, F
- Proctor, M
Producer: 19960801
In:
European journal of cancer (Oxford, England : 1990) vol. 31A
Availability: No items available.
|
|
|
262.
|
|
|
|
263.
|
Clinical pharmacokinetic and pharmacodynamic studies with the nonclassical antifolate thymidylate synthase inhibitor 3, 4-dihydro-2-amino-6-methyl-4-oxo-5-(4-pyridylthio)-quinazolone dihydrochloride (AG337) given by 24-hour continuous intravenous infusion. [electronic resource] by
- Rafi, I
- Taylor, G A
- Calvete, J A
- Boddy, A V
- Balmanno, K
- Bailey, N
- Lind, M
- Calvert, A H
- Webber, S
- Jackson, R C
Producer: 19990209
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 1
Availability: No items available.
|
|
|
264.
|
Carboplatin and granulocyte colony-stimulating factor as first-line treatment for epithelial ovarian cancer: a phase I dose-intensity escalation study. [electronic resource] by
- Calvert, A H
- Lind, M J
- Ghazal-Aswad, S
- Gumbrell, L
- Millward, M J
- Bailey, N P
- Doré-Green, F
- Chapman, F
- Simmons, D
- Proctor, M
Producer: 19950110
In:
Seminars in oncology vol. 21
Availability: No items available.
|
|
|
265.
|
Prostatic acid phosphatase levels (enzymatic method) from completely sectioned, clinically benign, whole prostates. [electronic resource] by
- Brawn, P N
- Jay, D W
- Foster, D M
- Kuhl, D
- Speights, V O
- Johnson, E H
- Riggs, M
- Lind, M L
- Coffield, K S
- Weaver, B
Producer: 19960530
In:
The Prostate vol. 28
Availability: No items available.
|
|
|
266.
|
Characteristics of prostatic infarcts and their effect on serum prostate-specific antigen and prostatic acid phosphatase. [electronic resource] by
- Brawn, P N
- Foster, D M
- Jay, D W
- Kuhl, D
- Speights, V O
- Johnson, E H
- Coffield, K S
- Lind, M L
- Karl, R
- Weaver, B
Producer: 19940819
In:
Urology vol. 44
Availability: No items available.
|
|
|
267.
|
|
|
|
268.
|
|
|
|
269.
|
Identification of the major human hepatic cytochrome P450 involved in activation and N-dechloroethylation of ifosfamide. [electronic resource] by
- Walker, D
- Flinois, J P
- Monkman, S C
- Beloc, C
- Boddy, A V
- Cholerton, S
- Daly, A K
- Lind, M J
- Pearson, A D
- Beaune, P H
Producer: 19940518
In:
Biochemical pharmacology vol. 47
Availability: No items available.
|
|
|
270.
|
Effect of liraglutide on anthropometric measurements, sagittal abdominal diameter and adiponectin levels in people with type 2 diabetes treated with multiple daily insulin injections: evaluations from a randomized trial (MDI-liraglutide study 5). [electronic resource] by
- Ahmadi, S S
- Filipsson, K
- Dimenäs, H
- Isaksson, S S
- Imberg, H
- Sjöberg, S
- Ahrén, B
- Dahlqvist, S
- Gustafsson, T
- Tuomilehto, J
- Hirsch, I B
- Lind, M
Publication details: Obesity science & practice Apr 2019
In:
Obesity science & practice vol. 5
Availability: No items available.
|
|
|
271.
|
Carboplatin and paclitaxel, alone and in combination: dose escalation, measurement of renal function, and role of the p53 tumor suppressor gene. [electronic resource] by
- Calvert, A H
- Ghokul, S
- Al-Azraqi, A
- Wright, J
- Lind, M
- Bailey, N
- Highley, M
- Siddiqui, N
- Lunec, J
- Sinha, D
- Boddy, A
- Roberts, T
- Fenwick, J
Producer: 19990413
In:
Seminars in oncology vol. 26
Availability: No items available.
|
|
|
272.
|
Changes in HbA [electronic resource] by
- Stener-Victorin, E
- Maliqueo, M
- Soligo, M
- Protto, V
- Manni, L
- Jerlhag, E
- Kokosar, M
- Sazonova, A
- Behre, C J
- Lind, M
- Ohlsson, C
- Højlund, K
- Benrick, A
Publication details: Obesity science & practice 12 2016
In:
Obesity science & practice vol. 2
Availability: No items available.
|
|
|
273.
|
Phase II study of pemetrexed in breast cancer patients pretreated with anthracyclines. [electronic resource] by
- Martin, M
- Spielmann, M
- Namer, M
- duBois, A
- Unger, C
- Dodwell, D
- Vodvarka, P
- Lind, M
- Calvert, H
- Casado, A
- Zelek, L
- Lluch, A
- Carrasco, E
- Kayitalire, L
- Zielinski, C
Producer: 20031017
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 14
Availability: No items available.
|
|
|
274.
|
Phase II studies of BBR3464, a novel tri-nuclear platinum complex, in patients with gastric or gastro-oesophageal adenocarcinoma. [electronic resource] by
- Jodrell, D I
- Evans, T R J
- Steward, W
- Cameron, D
- Prendiville, J
- Aschele, C
- Noberasco, C
- Lind, M
- Carmichael, J
- Dobbs, N
- Camboni, G
- Gatti, B
- De Braud, F
Producer: 20041012
In:
European journal of cancer (Oxford, England : 1990) vol. 40
Availability: No items available.
|
|
|
275.
|
Phase I study of temozolomide plus paclitaxel in patients with advanced malignant melanoma and associated in vitro investigations. [electronic resource] by
- Azzabi, A
- Hughes, A N
- Calvert, P M
- Plummer, E R
- Todd, R
- Griffin, M J
- Lind, M J
- Maraveyas, A
- Kelly, C
- Fishwick, K
- Calvert, A H
- Boddy, A V
Producer: 20050428
In:
British journal of cancer vol. 92
Availability: No items available.
|
|
|
276.
|
Preclinical and phase I clinical studies with the nonclassical antifolate thymidylate synthase inhibitor nolatrexed dihydrochloride given by prolonged administration in patients with solid tumors. [electronic resource] by
- Rafi, I
- Boddy, A V
- Calvete, J A
- Taylor, G A
- Newell, D R
- Bailey, N P
- Lind, M J
- Green, M
- Hines, J
- Johnstone, A
- Clendeninn, N
- Calvert, A H
Producer: 19980324
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 16
Availability: No items available.
|
|
|
277.
|
A phase II trial evaluating two schedules of sagopilone (ZK-EPO), a novel epothilone, in patients with platinum-resistant ovarian cancer. [electronic resource] by
- Rustin, G
- Reed, N
- Jayson, G C
- Ledermann, J A
- Adams, M
- Perren, T
- Poole, C
- Lind, M
- Persic, M
- Essapen, S
- Gore, M
- Calvert, H
- Stredder, C
- Wagner, A
- Giurescu, M
- Kaye, S
Producer: 20111219
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 22
Availability: No items available.
|
|
|
278.
|
A phase I and pharmacokinetic study of LY231514, the multitargeted antifolate. [electronic resource] by
- McDonald, A C
- Vasey, P A
- Adams, L
- Walling, J
- Woodworth, J R
- Abrahams, T
- McCarthy, S
- Bailey, N P
- Siddiqui, N
- Lind, M J
- Calvert, A H
- Twelves, C J
- Cassidy, J
- Kaye, S B
Producer: 19980528
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 4
Availability: No items available.
|
|
|
279.
|
Randomized comparison of progenitor-cell mobilization using chemotherapy, stem-cell factor, and filgrastim or chemotherapy plus filgrastim alone in patients with ovarian cancer. [electronic resource] by
- Weaver, A
- Chang, J
- Wrigley, E
- de Wynter, E
- Woll, P J
- Lind, M
- Jenkins, B
- Gill, C
- Wilkinson, P M
- Pettengell, R
- Radford, J A
- Collins, C D
- Dexter, T M
- Testa, N G
- Crowther, D
Producer: 19980831
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 16
Availability: No items available.
|
|
|
280.
|
A phase I clinical study of the antipurine antifolate lometrexol (DDATHF) given with oral folic acid. [electronic resource] by
- Laohavinij, S
- Wedge, S R
- Lind, M J
- Bailey, N
- Humphreys, A
- Proctor, M
- Chapman, F
- Simmons, D
- Oakley, A
- Robson, L
- Gumbrell, L
- Taylor, G A
- Thomas, H D
- Boddy, A V
- Newell, D R
- Calvert, A H
Producer: 19970414
In:
Investigational new drugs vol. 14
Availability: No items available.
|